2108.4000 66.00 (3.23%)
NSE Sep 18, 2025 15:31 PM
Volume: 1.1M
 

2108.40
3.23%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues declined 8.4% YoY to | 2165.6 crore (I-direct estimate: | 2201.3 crore) mainly due to 33% decline in the US to | 704 crore (Idirect estimate: | 727.5 crore) on the back of high base of gZetia exclusivity in Q1FY18. Europe, on the other hand, grew 35.6% YoY to | 219.8 crore (I-direct estimate: | 186.4 crore). India business grew 7.6% YoY to | 663.3 crore (I-direct estimate: | 690.4 crore) EBITDA margins contracted 842 bps YoY to 16.0% (I-direct estimate: 17.0%) attributable to higher base of gZetia exclusivity. EBITDA...
Glenmark Pharmaceuticals Ltd. has gained 44.77% in the last 6 Months
More from Glenmark Pharmaceuticals Ltd.
Recommended